The reciprocal interaction between obesity and obstructive sleep apnoea

Sleep Medicine Reviews

Volumn 17, Issue 2, 2013, Pages 123-131

  Ong, Chong Weng ^a   O'Driscoll, Denise M ^a,b   Truby, Helen ^b   Naughton, Matthew T ^b   Hamilton, Garun S ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Continuous positive airway pressure; Diet; Energy expenditure; Ghrelin; Leptin; Sleep disordered breathing; Weight gain; Weight loss

Indexed keywords

GHRELIN; LEPTIN; NEUROHORMONE;

DISEASE ASSOCIATION; EATING HABIT; ENERGY EXPENDITURE; HUMAN; HUNGER; METABOLIC DISORDER; OBESITY; PATHOGENESIS; REVIEW; SATIETY; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING; SLEEP TIME; WEIGHT REDUCTION;

HUMANS; OBESITY; SLEEP APNEA, OBSTRUCTIVE; WEIGHT REDUCTION PROGRAMS;

EID: 84873445194     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2012.05.002     Document Type: Review

References (108)

1. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377(9765):557-567.
2. Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 328(17):1230-1235.
3. Young T., Peppard P.E., Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005, 99(4):1592-1599.
4. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Javier Nieto F., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001, 163(1):19-25.
5. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342(19):1378-1384.
6. Wang H., Parker J.D., Newton G.E., Floras J.S., Mak S., Chiu K.L., et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007, 49(15):1625-1631.
7. Harsch I.A., Schahin S.P., Radespiel-Troger M., Weintz O., Jahreiss H., Fuchs F.S., et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004, 169(2):156-162.
8. Punjabi N.M., Sorkin J.D., Katzel L.I., Goldberg A.P., Schwartz A.R., Smith P.L. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002, 165(5):677-682.
9. Phillips B.G., Hisel T.M., Kato M., Pesek C.A., Dyken M.E., Narkiewicz K., et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 1999, 17(9):1297-1300.
10. Grunstein R.R. Metabolic aspects of sleep apnea. Sleep 1996, 19(10 Suppl.):S218-S220.
11. Peppard P.E., Young T., Palta M., Dempsey J., Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000, 284(23):3015-3021.
12. Young T., Shahar E., Nieto F.J., Redline S., Newman A.B., Gottlieb D.J., et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002, 162(8):893-900.
13. Tishler P.V., Larkin E.K., Schluchter M.D., Redline S. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003, 289(17):2230-2237.
14. Tuomilehto H.P., Seppa J.M., Partinen M.M., Peltonen M., Gylling H., Tuomilehto J.O., et al. Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med 2009, 179(4):320-327.
15. Johansson K., Neovius M., Lagerros Y.T., Harlid R., Rossner S., Granath F., et al. Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial. BMJ 2009, 339:b4609.
16. Foster G.D., Borradaile K.E., Sanders M.H., Millman R., Zammit G., Newman A.B., et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med 2009, 169(17):1619-1626.
17. Johansson K., Hemmingsson E., Harlid R., Trolle Lagerros Y., Granath F., Rossner S., et al. Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study. BMJ 2011, 342:d3017.
18. Schwartz A.R., Smith P.L., Wise R.A., Gold A.R., Permutt S. Induction of upper airway occlusion in sleeping individuals with subatmospheric nasal pressure. J Appl Physiol 1988, 64(2):535-542.
19. Schwartz A.R., Patil S.P., Squier S., Schneider H., Kirkness J.P., Smith P.L. Obesity and upper airway control during sleep. J Appl Physiol 2010, 108(2):430-435.
20. White D.P. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 2005, 172(11):1363-1370.
21. Schwab R.J., Gupta K.B., Gefter W.B., Metzger L.J., Hoffman E.A., Pack A.I. Upper airway and soft tissue anatomy in normal subjects and patients with sleep-disordered breathing. Significance of the lateral pharyngeal walls. Am J Respir Crit Care Med 1995, 152(5 Pt 1):1673-1689.
22. Schwab R.J., Pasirstein M., Pierson R., Mackley A., Hachadoorian R., Arens R., et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003, 168(5):522-530.
23. Barkdull G.C., Kohl C.A., Patel M., Davidson T.M. Computed tomography imaging of patients with obstructive sleep apnea. Laryngoscope 2008, 118(8):1486-1492.
24. Horner R.L., Mohiaddin R.H., Lowell D.G., Shea S.A., Burman E.D., Longmore D.B., et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 1989, 2(7):613-622.
25. Van de Graaff W.B. Thoracic influence on upper airway patency. J Appl Physiol 1988, 65(5):2124-2131.
26. Van de Graaff W.B. Thoracic traction on the trachea: mechanisms and magnitude. J Appl Physiol 1991, 70(3):1328-1336.
27. Stanchina M.L., Malhotra A., Fogel R.B., Trinder J., Edwards J.K., Schory K., et al. The influence of lung volume on pharyngeal mechanics, collapsibility, and genioglossus muscle activation during sleep. Sleep 2003, 26(7):851-856.
28. Sharp J.T., Henry J.P., Sweany S.K., Meadows W.R., Pietras R.J. The total work of breathing in normal and obese men. J Clin Invest 1964, 43:728-739.
29. Gifford A.H., Leiter J.C., Manning H.L. Respiratory function in an obese patient with sleep-disordered breathing. Chest 2010, 138(3):704-715.
30. Wellman A., Jordan A.S., Malhotra A., Fogel R.B., Katz E.S., Schory K., et al. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med 2004, 170(11):1225-1232.
31. Lavie P., Herer P., Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000, 320(7233):479-482.
32. Bixler E.O., Vgontzas A.N., Lin H.M., Ten Have T., Leiby B.E., Vela-Bueno A., et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000, 160(15):2289-2295.
33. Grote L., Ploch T., Heitmann J., Knaack L., Penzel T., Peter J.H. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999, 160(6):1875-1882.
34. O'Driscoll D.M., Morrell M.J. The interaction between respiratory and autonomic function during sleep-related changes in pharyngeal airway patency. Auton Neurosci 2005, 120(1-2):18-25.
35. Oldenburg O., Lamp B., Topfer V., Faber L., Teschler H., Horstkotte D. Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure. Dtsch Med Wochenschr 2007, 132(13):661-666.
36. Oldenburg O., Lamp B., Faber L., Teschler H., Horstkotte D., Topfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007, 9(3):251-257.
37. Levy P., Tamisier R., Minville C., Launois S., Pepin J.L. Sleep apnoea syndrome in 2011: current concepts and future directions. Eur Respir Rev 2011, 20(121):134-146.
38. Sutherland K., Lee R.W., Phillips C.L., Dungan G., Yee B.J., Magnussen J.S., et al. Effect of weight loss on upper airway size and facial fat in men with obstructive sleep apnoea. Thorax 2011, 66(9):797-803.
39. Schwartz A.R., Gold A.R., Schubert N., Stryzak A., Wise R.A., Permutt S., et al. Effect of weight loss on upper airway collapsibility in obstructive sleep apnea. Am Rev Respir Dis 1991, 144(3 Pt 1):494-498.
40. Polotsky M., Elsayed-Ahmed A.S., Pichard L., Richardson R.A., Smith P.L., Schneider H., et al. Effect of age and weight on upper airway function in a mouse model. J Appl Physiol 2011, 111(3):696-703.
41. Bluher S., Mantzoros C.S. Leptin in humans: lessons from translational research. Am J Clin Nutr 2009, 89(3):991S-997S.
42. Enriori P.J., Evans A.E., Sinnayah P., Cowley M.A. Leptin resistance and obesity. Obesity (Silver Spring) 2006, 14(Suppl. 5):254S-258S.
43. Phillips B.G., Kato M., Narkiewicz K., Choe I., Somers V.K. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000, 279(1):H234-H237.
44. Campo A., Fruhbeck G., Zulueta J.J., Iriarte J., Seijo L.M., Alcaide A.B., et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J 2007, 30(2):223-231.
45. Phipps P.R., Starritt E., Caterson I., Grunstein R.R. Association of serum leptin with hypoventilation in human obesity. Thorax 2002, 57(1):75-76.
46. Ozturk L., Unal M., Tamer L., Celikoglu F. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 2003, 129(5):538-540.
47. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259(5091):87-91.
48. Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998, 83(3):847-850.
49. Vgontzas A.N., Zoumakis E., Lin H.M., Bixler E.O., Trakada G., Chrousos G.P. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004, 89(9):4409-4413.
50. Churchill L., Rector D.M., Yasuda K., Fix C., Rojas M.J., Yasuda T., et al. Tumor necrosis factor alpha: activity dependent expression and promotion of cortical column sleep in rats. Neuroscience 2008, 156(1):71-80.
51. Arias M.A., Garcia-Rio F., Alonso-Fernandez A., Hernanz A., Hidalgo R., Martinez-Mateo V., et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 2008, 32(4):1009-1015.
52. Malhotra A., White D.P. Obstructive sleep apnoea. Lancet 2002, 360(9328):237-245.
53. Loube D.I., Loube A.A., Erman M.K. Continuous positive airway pressure treatment results in weight less in obese and overweight patients with obstructive sleep apnea. J Am Diet Assoc 1997, 97(8):896-897.
54. Chin K., Shimizu K., Nakamura T., Narai N., Masuzaki H., Ogawa Y., et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999, 100(7):706-712.
55. Ferland A., Poirier P., Series F. Sibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients. Eur Respir J 2009, 34(3):694-701.
56. Redenius R., Murphy C., O'Neill E., Al-Hamwi M., Zallek S.N. Does CPAP lead to change in BMI?. J Clin Sleep Med 2008, 4(3):205-209.
57. Sharma S.K., Agrawal S., Damodaran D., Sreenivas V., Kadhiravan T., Lakshmy R., et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011, 365(24):2277-2286.
58. Horton E.S. Introduction: an overview of the assessment and regulation of energy balance in humans. Am J Clin Nutr 1983, 38(6):972-977.
59. Siegel J.M. Clues to the functions of mammalian sleep. Nature 2005, 437(7063):1264-1271.
60. Jung C., Melanson E., Frydendall E., Perreault L., Eckel R., Wright K. Energy expenditure during sleep, sleep deprivation and sleep following sleep deprivation in adult humans. J Physiol 2011, 589(Pt 1):235-244.
61. Baarends E.M., Schols A.M., Westerterp K.R., Wouters E.F. Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD. Thorax 1997, 52(9):780-785.
62. Mannix E.T., Manfredi F., Farber M.O. Elevated O2 cost of ventilation contributes to tissue wasting in COPD. Chest 1999, 115(3):708-713.
63. Baarends E.M., Schols A.M., Akkermans M.A., Wouters E.F. Decreased mechanical efficiency in clinically stable patients with COPD. Thorax 1997, 52(11):981-986.
64. Bonnet M.H., Berry R.B., Arand D.L. Metabolism during normal, fragmented, and recovery sleep. J Appl Physiol 1991, 71(3):1112-1118.
65. Kezirian E.J., Kirisoglu C.E., Riley R.W., Chang E., Guilleminault C., Powell N.B. Resting energy expenditure in adults with sleep disordered breathing. Arch Otolaryngol Head Neck Surg 2008, 134(12):1270-1275.
66. Stenlof K., Grunstein R., Hedner J., Sjostrom L. Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol 1996, 271(6 Pt 1):E1036-E1043.
67. O'Driscoll D.M., Turton A.R., Copland J.M., Strauss B.J., Hamilton G.S. Energy expenditure in obstructive sleep apnea: validation of a multiple physiological sensor for determination of sleep and wake. Sleep Breath 2012, Epub Feb 10.
68. Ryan C.F., Love L.L., Buckley P.A. Energy expenditure in obstructive sleep apnea. Sleep 1995, 18(3):180-187.
69. Bland R.M., Bulgarelli S., Ventham J.C., Jackson D., Reilly J.J., Paton J.Y. Total energy expenditure in children with obstructive sleep apnoea syndrome. Eur Respir J 2001, 18(1):164-169.
70. Li A.M., Yin J., Chan D., Hui S., Fok T.F. Sleeping energy expenditure in paediatric patients with obstructive sleep apnoea syndrome. Hong Kong Med J 2003, 9(5):353-356.
71. Lin C.C., Chang K.C., Lee K.S. Effects of treatment by laser-assisted uvuloplasty on sleep energy expenditure in obstructive sleep apnea patients. Metabolism 2002, 51(5):622-627.
72. Harris M., Glozier N., Ratnavadivel R., Grunstein R.R. Obstructive sleep apnea and depression. Sleep Med Rev 2009, 13(6):437-444.
73. Basta M., Lin H.M., Pejovic S., Sarrigiannidis A., Bixler E., Vgontzas A.N. Lack of regular exercise, depression, and degree of apnea are predictors of excessive daytime sleepiness in patients with sleep apnea: sex differences. J Clin Sleep Med 2008, 4(1):19-25.
74. Kajaste S., Brander P.E., Telakivi T., Partinen M., Mustajoki P. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004, 5(2):125-131.
75. West S.D., Kohler M., Nicoll D.J., Stradling J.R. The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: a randomised controlled trial. Sleep Med 2009, 10(9):1056-1058.
76. Grunstein R.R., Stenlof K., Hedner J., Sjostrom L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord 1995, 19(6):410-418.
77. Beebe D.W., Miller N., Kirk S., Daniels S.R., Amin R. The association between obstructive sleep apnea and dietary choices among obese individuals during middle to late childhood. Sleep Med 2011, 12(8):797-799.
78. Zheng H., Berthoud H.R. Neural systems controlling the drive to eat: mind versus metabolism. Physiology (Bethesda) 2008, 23:75-83.
79. Punjabi N.M., Polotsky V.Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005, 99(5):1998-2007.
80. Spruyt K., Sans Capdevila O., Serpero L.D., Kheirandish-Gozal L., Gozal D. Dietary and physical activity patterns in children with obstructive sleep apnea. J Pediatr 2010, 156(5):724-730. 730 e1-730 e3.
81. Lutter M., Sakata I., Osborne-Lawrence S., Rovinsky S.A., Anderson J.G., Jung S., et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 2008, 11(7):752-753.
82. Wing R.R., Phelan S. Long-term weight loss maintenance. Am J Clin Nutr 2005, 82(1 Suppl.):222S-225S.
83. Major G.C., Doucet E., Trayhurn P., Astrup A., Tremblay A. Clinical significance of adaptive thermogenesis. Int J Obes (Lond) 2007, 31(2):204-212.
84. Leibel R.L., Rosenbaum M., Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med 1995, 332(10):621-628.
85. Hins J., Series F., Almeras N., Tremblay A. Relationship between severity of nocturnal desaturation and adaptive thermogenesis: preliminary data of apneic patients tested in a whole-body indirect calorimetry chamber. Int J Obes (Lond) 2006, 30(3):574-577.
86. Mantzoros C.S., Magkos F., Brinkoetter M., Sienkiewicz E., Dardeno T.A., Kim S.Y., et al. Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 2011, 301(4):E567-E584.
87. Williams K.W., Scott M.M., Elmquist J.K. From observation to experimentation: leptin action in the mediobasal hypothalamus. Am J Clin Nutr 2009, 89(3):985S-990S.
88. Mantzoros C.S., Moschos S., Avramopoulos I., Kaklamani V., Liolios A., Doulgerakis D.E., et al. Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. J Clin Endocrinol Metab 1997, 82(10):3408-3413.
89. Inui A., Asakawa A., Bowers C.Y., Mantovani G., Laviano A., Meguid M.M., et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 2004, 18(3):439-456.
90. Kojima M., Kangawa K. Ghrelin, an orexigenic signaling molecule from the gastrointestinal tract. Curr Opin Pharmacol 2002, 2(6):665-668.
91. Pusztai P., Sarman B., Ruzicska E., Toke J., Racz K., Somogyi A., et al. Ghrelin: a new peptide regulating the neurohormonal system, energy homeostasis and glucose metabolism. Diabetes Metab Res Rev 2008, 24(5):343-352.
92. Caro J.F., Kolaczynski J.W., Nyce M.R., Ohannesian J.P., Opentanova I., Goldman W.H., et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996, 348(9021):159-161.
93. Banks W.A., DiPalma C.R., Farrell C.L. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 1999, 20(11):1341-1345.
94. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Hopper K., Lotsikas A., Lin H.M., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85(3):1151-1158.
95. Harsch I.A., Konturek P.C., Koebnick C., Kuehnlein P.P., Fuchs F.S., Pour Schahin S., et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003, 22(2):251-257.
96. Cuhadaroglu C., Utkusavas A., Ozturk L., Salman S., Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 2009, 187(2):75-81.
97. Sanner B.M., Kollhosser P., Buechner N., Zidek W., Tepel M. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 2004, 23(4):601-604.
98. Drummond M., Winck J.C., Guimaraes J.T., Santos A.C., Almeida J., Marques J.A. Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients. BMC Pulm Med 2008, 8:21.
99. Takahashi K., Chin K., Akamizu T., Morita S., Sumi K., Oga T., et al. Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment. Respirology 2008, 13(6):810-816.
100. Garcia J.M., Sharafkhaneh H., Hirshkowitz M., Elkhatib R., Sharafkhaneh A. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity. Respir Res 2011, 12(1):80.
101. Brondel L., Romer M.A., Nougues P.M., Touyarou P., Davenne D. Acute partial sleep deprivation increases food intake in healthy men. Am J Clin Nutr 2010, 91(6):1550-1559.
102. Nedeltcheva A.V., Kilkus J.M., Imperial J., Kasza K., Schoeller D.A., Penev P.D. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr 2009, 89(1):126-133.
103. Spiegel K., Tasali E., Penev P., Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141(11):846-850.
104. Chaput J.P., Despres J.P., Bouchard C., Tremblay A. The association between short sleep duration and weight gain is dependent on disinhibited eating behavior in adults. Sleep 2011, 34(10):1291-1297.
105. Marshall N.S., Glozier N., Grunstein R.R. Is sleep duration related to obesity? A critical review of the epidemiological evidence. Sleep Med Rev 2008, 12(4):289-298.
106. Patel S.R., Hu F.B. Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring) 2008, 16(3):643-653.
107. Cappuccio F.P., Taggart F.M., Kandala N.B., Currie A., Peile E., Stranges S., et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep 2008, 31(5):619-626.
108. Nielsen L.S., Danielsen K.V., Sorensen T.I. Short sleep duration as a possible cause of obesity: critical analysis of the epidemiological evidence. Obes Rev 2011, 12(2):78-92.